Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs specifically designed to treat liver fibrosis. Our Phase 2 trial of hydronidone for ...
For many years, it was believed that when an individual develops liver scarring, it can not be reversed. Today, we know that ...
For centuries, natural henna has been prized as a cosmetic dye used to colour skin, hair, and fabrics. Now, scientists have discovered that this traditional plant may hold remarkable healing potential ...
When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...
Add Yahoo as a preferred source to see more of our stories on Google. A Cell Metabolism study reports that EVT0185 reduced scarring in disease models and may offer a new path for treating MASH.
PLAINSBORO, N.J., Aug. 15, 2025 /PRNewswire/ -- Novo Nordisk (NVO) today announced that the US Food and Drug Administration (FDA) has approved a new indication for Wegovy ® (semaglutide) injection 2.4 ...
Semaglutide significantly improved liver fibrosis and steatohepatitis resolution in MASH patients over 72 weeks compared to placebo. The study involved 800 patients receiving semaglutide and 400 ...
Microscopy image showing activated hepatic stellate cells (HSCs), indicated by red staining (left image). Inhibition of CYB1B1 reduces HSC activation (right image), which leads to reduced liver ...
The FDA approved the obesity drug Wegovy as a treatment for people with MASH fibrosis. It’s the second drug approved to treat scarring in people with the advanced fatty liver disease Experts say ...
Liver fibrosis may be diagnosed and staged — no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) — with the use of clinical parameters and ...
The investigators explained that GLP-1 receptor agonists appear to be able to help resolve MASH without worsening fibrosis. Those findings have been confirmed in mouse models and in multiple studies ...
Congenital hepatic fibrosis is a type of liver disease that is present from birth. It typically affects the function of the bile ducts and the veins that carry blood from the digestive tract to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results